Anakinra treatment efficacy in reduction of inflammatory biomarkers in COVID‐19 patients: A meta‐analysis

INTRODUCTION: Anakinra is being empirically considered for the treatment of COVID‐19 patients. The aim is to assess the efficacy of anakinra treatment on inflammatory marker reduction, including c‐reactive protein (CRP) concentrations, serum ferritin, and serum d‐dimer levels. METHODS: Adhering to P...

Descripción completa

Detalles Bibliográficos
Autores principales: Naveed, Zunaira, Sarwar, Musharraf, Ali, Zahid, Saeed, Danish, Choudhry, Khadija, Sarfraz, Azza, Sarfraz, Zouina, Felix, Miguel, Cherrez‐Ojeda, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110982/
https://www.ncbi.nlm.nih.gov/pubmed/35435272
http://dx.doi.org/10.1002/jcla.24434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110982/
https://www.ncbi.nlm.nih.gov/pubmed/35435272
http://dx.doi.org/10.1002/jcla.24434

Ejemplares similares